| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |